Suchergebnisse - "Koudijs, Karel K M"

PubPharm (8)

1

Validation of transcriptome signature reversion for drug repurposing in oncology

enthalten in: Briefings in bioinformatics | 2023

von Koudijs, K. | Böhringer, S. | Guchelaar, H.

2

Influence of batch effect correction methods on drug induced differential gene expression profiles

enthalten in: BMC bioinformatics | 2019

von Zhou, W. | Koudijs, K. | Böhringer, S.

3

Influence of batch effect correction methods on drug induced differential gene expression profiles

enthalten in: BMC bioinformatics | 2019

von Zhou, W. | Koudijs, K. | Böhringer, S.

4

Influence of batch effect correction methods on drug induced differential gene expression profiles

enthalten in: BMC bioinformatics | 2019

von Zhou, W. | Koudijs, K. | Böhringer, S.

5

Transcriptome Signature Reversion as a Method to Reposition Drugs Against Cancer for Precision Oncology

enthalten in: Cancer journal (Sudbury, Mass.) | 2019

von Koudijs, K. | Terwisscha van Scheltinga, A. | Böhringer, S. | +2

6

The impact of estimated tumour purity on gene expression-based drug repositioning of Clear Cell Renal Cell Carcinoma samples

enthalten in: Scientific reports | 2019

von Koudijs, K. | Terwisscha van Scheltinga, A. | Böhringer, S. | +2

7

A Genetic Polymorphism in CTLA-4 Is Associated with Overall Survival in Sunitinib-Treated Patients with Clear Cell Metastatic Renal Cell Carcinoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2018

von Liu, X. | Swen, J. | Diekstra, M. | +21

8

Personalised drug repositioning for Clear Cell Renal Cell Carcinoma using gene expression

enthalten in: Scientific reports | 2018

von Koudijs, K. | Terwisscha van Scheltinga, A. | Böhringer, S. | +2

1
[1]